依达拉奉联用醒脑静治疗急性脑出血79例临床疗效  

Clinical efficacy of edaravone combined with Xingnaojing in treating 79 cases of acute cerebral hemorrhage

作　　者：胡明珠[1] Hu Mingzhu(Department of Emergency,the People＇s Hospital of Jishou City in Hunan Province（Xiangxi）416000)

机构地区：[1]湖南省吉首市人民医院急诊科,湘西416000

出　　处：《中国社区医师》2018年第24期83-84,共2页Chinese Community Doctors

摘　　要：目的:探讨依达拉奉联合醒脑静治疗急性脑出血的疗效。方法:收治急性脑出血患者150例,根据治疗方案不同分为对照组和观察组。对照组患者采用依达拉奉治疗,观察组联合醒脑静治疗。比较两组治疗效果。结果:观察组治疗后神经功能缺损评分、日常生活能力评分优于对照组(P<0.05)。两组治疗后神经元特异性烯醇化酶(NSE)、S100B蛋白差异有统计学意义(P<0.05)。结论:依达拉奉联合醒脑静治疗急性脑出血可以改善患者神经缺损功能,调节体内神经因子浓度。Objective：To explore the efficacy of edaravone combined with Xingnaojing in the treatment of acute cerebral hemorrhage.Methods：150 patients with acute cerebral hemorrhage were divided into the control group and observation group according to different treatment regimens.The patients in the control group were treated with edaravone,and the observation group was treated with Xingnaojing.Results：The neurological deficit score and activity of daily living score in the observation group were better than those in the control group（P〈0.05）.The difference of NSE and S100 B protein between the two groups after treatment was statistically significant（P〈0.05）.Conclusion：Edaravone combined with Xingnaojing in the treatment of acute intracerebral hemorrhage can improve the neurological deficit function and regulate the concentration of nerve factor in the body.

关 键 词：依达拉奉 醒脑静 急性脑出血 

分 类 号：R743.34[医药卫生—神经病学与精神病学]